We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current GLSI market cap is 134.62M. The company's latest EPS is USD -1.1811 and P/E is -8.53.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -2.84M | -2.54M | -2.66M | -2.73M | -8.09M |
| Net Income | -2.75M | -2.47M | -2.61M | -2.67M | -8.04M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -1.86M | -4.6M | -8.04M | -9.33M | -16.01M |
| Net Income | -1.86M | -4.57M | -7.83M | -8.89M | -15.79M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 7M | 5.51M | 7.23M | 5.83M | 4.09M |
| Total Liabilities | 295k | 389k | 1.35M | 842k | 1.56M |
| Total Equity | 6.7M | 5.12M | 5.88M | 4.98M | 2.53M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 28.68M | 27.22M | 13.48M | 7M | 4.09M |
| Total Liabilities | 1.05M | 385k | 263k | 295k | 1.56M |
| Total Equity | 27.63M | 26.83M | 13.21M | 6.7M | 2.53M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -6.48M | -1.78M | -2.83M | -5.41M | -7.27M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | N/A | 299k | 3.07M | 4.25M | 4.37M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -1.15M | -4.29M | -6.2M | -6.48M | -7.27M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 29.81M | 2.84M | -7.54M | N/A | 4.37M |
| Market Cap | 134.62M |
| Price to Earnings Ratio | -8.53 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 32.9 |
| Price to Book Ratio | 53.13 |
| Dividend Yield | - |
| Shares Outstanding | 13.37M |
| Average Volume (1 week) | 45.41k |
| Average Volume (1 Month) | 40.47k |
| 52 Week Change | -40.17% |
| 52 Week High | 17.1882 |
| 52 Week Low | 8.06 |
| Spread (Intraday) | 0.65 (6.13%) |
| Company Name | Greenwich LifeSciences Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.greenwichlifesciences.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
